Companies / Vivaldi Biosciences
Vivaldi Biosciences
Company
Vivaldi Biosciences is developing vaccines for protection against epidemic and pandemic viral respiratory diseases.
Vivaldi Biosciences has 2 investors on file, among them Bay City Capital and Flu Lab. Its site was last checked 6 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Investor |
More from Bay City Capital
20 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (95%), Food & Agriculture (5%).
See Bay City Capital's full profile · Who invests alongside it
More from Flu Lab
20 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (88%), Education (12%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Vivaldi Biosciences and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Bay City Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/vivaldibiosciences.com/investors
# also
GET /v1/companies/vivaldibiosciences.com
GET /v1/companies/vivaldibiosciences.com/news